M. Tomirotti

1.7k citations
32 papers · 907 · 1 hit paper · h-index 14

Impact in

Papers in

    • Lung Cancer Treatments and Mutations 5
    • Sarcoma Diagnosis and Treatment 3
    • Lung Cancer Diagnosis and Treatment 3
    • Gastric Cancer Management and Outcomes 3
    • Vascular Tumors and Angiosarcomas 3
    • Cancer Treatment and Pharmacology 2

M. Tomirotti

32 papers receiving 879 citations

M. Tomirotti's Hit Papers

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial 2013 · 377 citations
3770+4+8Years since publication100200300

Peers

M. Tomirotti
Comparison fields: 5 of 86
  • Emergency Medical Services 89
  • Pulmonary and Respiratory Medicine 416
  • Oncology 338
  • Neurology 73
  • Genetics 52
Replace J P Kleisbauer with:
J P Kleisbauer France
Emanuele Naglieri Italy
Laurence Venat‐Bouvet France
Renata D’Alpino Peixoto Brazil
N. Willich Germany
Philippe Quétin France
Jeffrey P. Lamont United States
Elrasheid A. H. Kheirelseid Ireland
Margot J. Burnell Canada
Serdar Soyuer Türkiye
M. Tomirotti relative to J P Kleisbauer France J P Kleisbauer's profile →
Citations per field
00.5×3.3×
J P Kleisbauer · 1×
Citations per year

Countries citing papers authored by M. Tomirotti

Since Specialization
Citations

This map shows the geographic impact of M. Tomirotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Tomirotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Tomirotti more than expected).

Fields of papers citing papers by M. Tomirotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Tomirotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Tomirotti. The network helps show where M. Tomirotti may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Tomirotti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Tomirotti Line = papers co-authored together M. Tomirotti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
Hit paper breakdown →
2013377
2 1999100
3 200176
4 201665
5 201243
6 197738
7 198431
8 201222
9 200919
10 201017
11 197915
12 199315
13 198813
14 201113
15
Pharmacokinetics and bioavailability of metoclopramide nasal spray versus metoclopramide intravenous in healthy volunteers and cancer patients.
199310
16 20138
17 20156
18 19946
19 20185
20 20025

About M. Tomirotti

M. Tomirotti is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 32 papers that have together received 907 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Sarcoma Diagnosis and Treatment (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Vascular Tumors and Angiosarcomas (3 papers), Gastric Cancer Management and Outcomes (3 papers), Nausea and vomiting management (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Emergency Medical Services (89 citations), Pulmonary and Respiratory Medicine (416 citations), Oncology (338 citations), Neurology (73 citations) and Genetics (52 citations). M. Tomirotti has collaborated with scholars based in Italy, Switzerland and Belgium. Frequent co-authors include A. Scanni, Gabriella Farina, Olga Martelli, Marina Chiara Garassino, Roberto Labianca, Silvio Veronese, Mirko Marabese, Irene Floriani, Anna Bettini and Calogero Lauricella. Their work appears in journals such as Journal of Clinical Oncology, Oncology, Tumori Journal, BMJ Open and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact